Serialization in a CMO Environment
Strategic approaches for becoming serialization-ready — Faced with pending regulations, product diversion and drug counterfeiting, pharmaceutical manufacturers are exploring serialization as a means to not only prepare for future regulatory compliance, but also reap the business benefits as well. A complex undertaking to begin with, serialization is further complicated when a company relies on multiple vendors for packaging and logistics. With the global pharmaceutical contract manufacturing market on the rise and expected to reach $40 billion by 2015,1 the issues surrounding implementing a serialization strategy with multiple vendors are not going away.